DRS

NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch

Retrieved on: 
Monday, October 4, 2021
Mental Health Awareness Month, Mental disorder, Partnership, DRS, American Foundation for Suicide Prevention, Johns Hopkins School of Medicine, Lists of diseases, NASDAQ, Depression, FDA, Transcranial magnetic stimulation, Lincoln Memorial, Patient, Mental Illness Awareness Week, Lincoln Memorial University, Physician, TMS, National Alliance, Mental health, Marketing, Suicide, CEO, AFSP, Shepard, Advanced Therapy Medicinal Product, Awareness, Technology, Research, Neuroscience, Organization, NAMI, Quality of life, National Alliance on Mental Illness, STIM, Industry, Education, GLOBE, Medicine, Pharmaceutical industry

NeuroStar Advanced Therapy for Mental Health is the leading non-drug, non-invasive, transcranial magnetic stimulation (TMS) treatment for depression.

Key Points: 
  • NeuroStar Advanced Therapy for Mental Health is the leading non-drug, non-invasive, transcranial magnetic stimulation (TMS) treatment for depression.
  • NeuroStar is delighted to be partnering with Dr. Melissa Shepard to educate those suffering with major depression, their loved ones, and healthcare professionals about our breakthrough technology during National Depression Education and Awareness Month, said Keith J. Sullivan, President and CEO of Neuronetics.
  • Dr. Shepard shares our passion for helping transform lives; this partnership and the accompanying campaign will help patients and physicians see how conquering depression can become a reality.
  • She and NeuroStar are collaborating to kick off an education and awareness campaign.

Avail Dermatology Joins Epiphany Dermatology

Retrieved on: 
Friday, October 1, 2021
Partnership, DRS, Compliance, American College of Mohs Surgery, University, Duke University, Mohs surgery, Patient, Physician, Health, MD, American College, Dermatology, Marketing, Environment, Entrepreneurship, Veterinary medicine, Medical device

AUSTIN, Texas, Oct. 1, 2021 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence into the state of Georgia through its partnership with Avail Dermatology.

Key Points: 
  • AUSTIN, Texas, Oct. 1, 2021 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence into the state of Georgia through its partnership with Avail Dermatology.
  • Originally founded in 1990, Avail Dermatology has a long-established reputation of providing high-quality dermatology services to patients in the greater Atlanta area.
  • Avail Dermatology offers a broad range of dermatology products and services including medical, surgical, Mohs surgery, and cosmetic dermatology services.
  • By forming this partnership with Epiphany, Avail gains access to best-in-class expertise in medical practice management, and partnership with the nearly 100 Epiphany dermatologists .

The Prostate Cancer Foundation And Movember Announce 2021 Challenge Award Winners

Retrieved on: 
Friday, October 1, 2021
DRS, Man, Principal investigator, Research, Dana–Farber Cancer Institute, Diagnosis, University of California, Food, PCF, Health, Movember, Distinguished Gentleman's Ride, Patient, Precision medicine, Prostate Cancer Foundation, Prostate cancer, Biology, Netherlands Cancer Institute, Immunotherapy, Death, Medicine, University, Face, Testicular cancer, Life, Tuskegee University, Wayne State University, MPH, Mental health, Science, University of California, San Francisco, Distinguishing, Movement, Doctor of Philosophy, Men's Health, Karmanos Cancer Institute, Pharmaceutical industry, Medical imaging

LOS ANGELES, Oct. 1, 2021 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and Movember today announced two new Movember PCF Challenge Awards.

Key Points: 
  • LOS ANGELES, Oct. 1, 2021 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) and Movember today announced two new Movember PCF Challenge Awards.
  • Co-Investigators:Mark Pomerantz, MD (Dana-Farber Cancer Institute), Wilbert Zwart, PhD (The Netherlands Cancer Institute), Sylvan Baca, MD, PhD (Dana-Farber Cancer Institute), Tesa Severson, PhD (Netherlands Cancer Institute).
  • The team is also developing a prostate cancer research resource, which will help other investigators uncover novel biology and treatment opportunities for prostate cancer patients.
  • The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization dedicated to funding life-saving prostate cancer research.

Wesana Health Announces Inclusion in the AdvisorShares Psychedelics ETF

Retrieved on: 
Friday, October 1, 2021
Biotechnology, News, Failure, Health, CSE, Patient, Fund, ETF, Central nervous system, Phrase, GLOBE, Company, SEDAR, Risk, COVID-19, Research, DRS, WESA, Transaction, NYSE Arca, Budget, Pharmaceutical industry, Risk management

Chad Bronstein, Executive Chairman of Wesana, commented: We are incredibly pleased to have been selected as a core constituent in the new AdvisorShares Psychedelics ETF.

Key Points: 
  • Chad Bronstein, Executive Chairman of Wesana, commented: We are incredibly pleased to have been selected as a core constituent in the new AdvisorShares Psychedelics ETF.
  • Inclusion in this ETF is another validation in the evolution of Wesana as a publicly traded company and the impact Wesanas core initiatives have had on the psychedelics sector.
  • Wesana Health is an emerging life sciences company championing the development of innovative approaches for better understanding, protecting and improving neurological health and performance.
  • Through extensive clinical research and academic partnerships, Wesana Health is developing evidence-based formulations and protocols, including psilocybin-based therapies, that empower patients to overcome neurological, psychological and mental health ailments.

NSF-Funded Network for Advanced NMR Orders Two 1.1 GHz NMR Systems to Advance Protein Structure and Dynamics Research

Retrieved on: 
Friday, October 1, 2021
Research, Science, DRS, NSF, Molecular biology, Hertz, Network, Solution, Augustus A. Bird, NMR, University of Wisconsin–Madison, Biophysics, Multimedia, Microscopy, UHF, Chemistry, Cell biology, Biochemistry, Corporation, University, Acquisition, National Science Foundation, Proteomics, Life, Bruker, University of Connecticut School of Medicine, NAN, Technology, Science, Madison, Research, Tissue, Connecticut, Nasdaq, Protein, Pharmaceutical industry, Fine chemical

NSF awarded the funds to establish the Network for Advanced NMR (NAN) linking three institutions including the University of Connecticut School of Medicine, the University of Georgia and University of WisconsinMadison.

Key Points: 
  • NSF awarded the funds to establish the Network for Advanced NMR (NAN) linking three institutions including the University of Connecticut School of Medicine, the University of Georgia and University of WisconsinMadison.
  • The hub at the University of Connecticut will facilitate access to state-of-the-art NMR instrumentation, experimental protocols, and expertise from US researchers.
  • One 1.1 GHz NMR system will be installed at University of Wisconsin - Madison for solid-state NMR research, while the second system will be installed at the University of Georgia for solution-state NMR studies.
  • There will be targeted outreach programs focused on undergraduate and minority serving institutions that will promote a broadening participation in the NMR research community.

NhTherAguix: NH THERAGUIX announces the enrolment in Boston of the 2 first patients in its clinical trials NANOBRAINMETS Phase II targeting brain metastasis and NANOSMART Phase Ib/II targeting pancrea

Retrieved on: 
Friday, October 1, 2021
Phase II, University of Lyon, Neoplasm, DRS, Radiation, Diagnosis, Pancreatic cancer, Patient, Recurrence, Brain, Regulatory News Service, NH, Phases of clinical research, Method, CEO, Medicine, University, ILM, Technology, NIH, NHT, Survival, Nanoparticle, Safety, Nanomedicine, Quality of life, Pharmaceutical industry, Medical imaging, AGUIX(R), NH THERAGUIX

NANOBRAINMETS is a double-blind, placebo-controlled randomized Phase II clinical trial of stereotactic radiation with or without AGuIX(R) gadolinium-based nanoparticles in the management of brain metastases at higher-risk of local recurrence with radiation alone.

Key Points: 
  • NANOBRAINMETS is a double-blind, placebo-controlled randomized Phase II clinical trial of stereotactic radiation with or without AGuIX(R) gadolinium-based nanoparticles in the management of brain metastases at higher-risk of local recurrence with radiation alone.
  • This study follows the results already obtained by NH TherAguix through the NANORAD Phase I trial that demonstrated very promising results [1] .
  • Dr. Ayal Aizer stated, "Increasingly, the mainstay of management for patients with brain metastases involves brain-directed stereotactic radiation.
  • AGuIX(R) is currently also being tested through another Phase II trial in brain metastasis, using whole brain radiation therapy (NANORAD 2).

Akron Physicians Recognized for Excellence in Senior Patient Care Honored During National Primary Care Week

Retrieved on: 
Thursday, September 30, 2021
DRS, Instagram, Health, Medicare, Patient, Physician, YouTube, Twitter, National, Conditional sentence, Patient Centered Primary Care Collaborative, Movement, Time, Pinta, Health insurance

of Pioneer Physicians Network are among a select group of primary care physicians chosen out of 1,000 independent primary care physicians nationwide to be honored as "Best Physicians" during National Primary Care Week, Oct. 4-8.They were recognized for providing exemplary and innovative health care to improve the lives of senior patients.

Key Points: 
  • of Pioneer Physicians Network are among a select group of primary care physicians chosen out of 1,000 independent primary care physicians nationwide to be honored as "Best Physicians" during National Primary Care Week, Oct. 4-8.They were recognized for providing exemplary and innovative health care to improve the lives of senior patients.
  • Still, a concerning trend documented by the Primary Care Collaborative shows the decline in funding allocated to primary care services.
  • This comes at a time when the nation's senior population is rising -- causing a greater need for primary care physicians.
  • National Primary Care Week highlights the importance of primary care in the overall U.S. healthcare system.

Teens & Technology Focus of Opening Keynote for National Symposium, Led by Two Newport Healthcare Youth Mental Health Experts

Retrieved on: 
Wednesday, September 29, 2021
Social media, DRS, Intelligence, American Psychological Association, Review, Psychology, DAC, Behavior, Parent, APA, Intensive outpatient program, Student, Multimedia, Patient, LMFT, Outpatient commitment, Newport Academy, Child, Communication, Family therapy, Socialization, Mental health, COVID-19, Rupture, Research, Work, Addiction, Doctor of Philosophy, Digital, Newports Institute of Communications and Economics, Toy, Medicine

Today and Friday, two of the nation's top mental health experts will open a major behavioral health conference to address an additional concerning trend with teens and tech .

Key Points: 
  • Today and Friday, two of the nation's top mental health experts will open a major behavioral health conference to address an additional concerning trend with teens and tech .
  • This innovative presentation will explore how a parent or caregiver's engagement with devices can impact emotional and social attachment development in children.
  • In psychology, attachment theory explains how the parent-child relationship emerges and influences subsequent social and emotional development.
  • Dr. Grant is an internationally award-winning media psychologist, published researcher, clinician, and educator with specific expertise in technology's impact on mental health.

SportGait Adds Stress, Anxiety, and Depression Screener to Mobile App

Retrieved on: 
Wednesday, September 29, 2021
Newton, ADHD, Educational psychology, Kamphaus, Texas A&M University, DRS, Depression, Parent, Concussion, UNLV College of Education, University of Oregon, Patient, Neuropsychology, Texas, Athlete, CEO, University, Anxiety, Emotion, Mental health, COVID-19, Research, Brain, Safety, Doctor of Philosophy, College, Disorder, Health insurance, Toy, Medicine

WILMINGTON, N.C., Sept. 29, 2021 /PRNewswire/ --SportGait has announced an addition of a Stress, Anxiety, and Depression (S.A.D.)

Key Points: 
  • WILMINGTON, N.C., Sept. 29, 2021 /PRNewswire/ --SportGait has announced an addition of a Stress, Anxiety, and Depression (S.A.D.)
  • The screener was developed by Cecil R. Reynolds, PhD, who is a distinguished research scholar at Texas A&M University.
  • "If we do not screen our youth for mental health risk or disorders, we cannot ensure timely access to needed treatment."
  • The screener is based on the BASC-3 Behavioral and Emotional Screening System, also developed by Drs.

The Cannabinoid Institute Offers Medical Cannabis Training Courses Free of Charge to 100 Medical Students in New York State

Retrieved on: 
Wednesday, September 29, 2021
DRS, NYU, DSW, Student, Patient, Physician, Certification, Health, Social work, Anadan, MSW, Method, Program, Knowledge, Faculty, TCI, Patient safety, LCSW, Drug, Science, Silver, Cannabis, Private practice, Medicine, Education

NEW YORK, Sept. 29, 2021 /PRNewswire/ -- The Cannabinoid Institute (TCI) announced today it is offering its cannabis training certification courses free of chargeto100medicalstudentsinthe state ofNew York.

Key Points: 
  • NEW YORK, Sept. 29, 2021 /PRNewswire/ -- The Cannabinoid Institute (TCI) announced today it is offering its cannabis training certification courses free of chargeto100medicalstudentsinthe state ofNew York.
  • Courses will be awarded tothe first 100applicants who supply proof of their status as enrolled NY state medical studentsat [email protected] .
  • Withmore stateslegalizing cannabisformedicalandrecreationaluse, TCIrecognizes the critical role that education plays in reducing patient adverse outcomes and ensuringthesafe useof cannabis.
  • Medical students who register for the program will have access toeighthours of medical cannabis education, including the latest scientific research on the endocannabinoid system and the known effects of cannabis on the human body.